195 related articles for article (PubMed ID: 1464157)
1. Identification of metabolites of the antitumor agent d-limonene capable of inhibiting protein isoprenylation and cell growth.
Crowell PL; Lin S; Vedejs E; Gould MN
Cancer Chemother Pharmacol; 1992; 31(3):205-12. PubMed ID: 1464157
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships among monoterpene inhibitors of protein isoprenylation and cell proliferation.
Crowell PL; Ren Z; Lin S; Vedejs E; Gould MN
Biochem Pharmacol; 1994 Apr; 47(8):1405-15. PubMed ID: 8185648
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of protein prenylation by metabolites of limonene.
Hardcastle IR; Rowlands MG; Barber AM; Grimshaw RM; Mohan MK; Nutley BP; Jarman M
Biochem Pharmacol; 1999 Apr; 57(7):801-9. PubMed ID: 10075086
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of active drug metabolites after oral administration of perillyl alcohol, an investigational antineoplastic agent, to the dog.
Phillips LR; Malspeis L; Supko JG
Drug Metab Dispos; 1995 Jul; 23(7):676-80. PubMed ID: 7587953
[TBL] [Abstract][Full Text] [Related]
5. Selective inhibition of isoprenylation of 21-26-kDa proteins by the anticarcinogen d-limonene and its metabolites.
Crowell PL; Chang RR; Ren ZB; Elson CE; Gould MN
J Biol Chem; 1991 Sep; 266(26):17679-85. PubMed ID: 1894647
[TBL] [Abstract][Full Text] [Related]
6. The inhibition of protein prenyltransferases by oxygenated metabolites of limonene and perillyl alcohol.
Gelb MH; Tamanoi F; Yokoyama K; Ghomashchi F; Esson K; Gould MN
Cancer Lett; 1995 May; 91(2):169-75. PubMed ID: 7767906
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of tumor cell growth by monoterpenes in vitro: evidence of a Ras-independent mechanism of action.
Karlson J; Borg-Karlson AK; Unelius R; Shoshan MC; Wilking N; Ringborg U; Linder S
Anticancer Drugs; 1996 Jun; 7(4):422-9. PubMed ID: 8826611
[TBL] [Abstract][Full Text] [Related]
8. Effects of monoterpenes and mevinolin on murine colon tumor CT-26 in vitro and its hepatic "metastases" in vivo.
Broitman SA; Wilkinson J; Cerda S; Branch SK
Adv Exp Med Biol; 1996; 401():111-30. PubMed ID: 8886130
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of perillic acid in humans after a single dose administration of a citrus preparation rich in d-limonene content.
Chow HH; Salazar D; Hakim IA
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1472-6. PubMed ID: 12433729
[TBL] [Abstract][Full Text] [Related]
10. Prenylated proteins and lymphocyte proliferation: inhibition by d-limonene related monoterpenes.
Schulz S; Bühling F; Ansorge S
Eur J Immunol; 1994 Feb; 24(2):301-7. PubMed ID: 8299679
[TBL] [Abstract][Full Text] [Related]
11. Effect of perillic acid, a putative isoprenylation inhibitor, on the cultured rat lens.
Cheng QF; Rao PV; Zigler JS
Exp Eye Res; 2001 Aug; 73(2):239-45. PubMed ID: 11446774
[TBL] [Abstract][Full Text] [Related]
12. Chemoprevention and therapy of cancer by d-limonene.
Crowell PL; Gould MN
Crit Rev Oncog; 1994; 5(1):1-22. PubMed ID: 7948106
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of limonene metabolites in patients with advanced cancer by liquid chromatography/mass spectrometry.
Poon GK; Vigushin D; Griggs LJ; Rowlands MG; Coombes RC; Jarman M
Drug Metab Dispos; 1996 May; 24(5):565-71. PubMed ID: 8723738
[TBL] [Abstract][Full Text] [Related]
14. Human metabolism of the experimental cancer therapeutic agent d-limonene.
Crowell PL; Elson CE; Bailey HH; Elegbede A; Haag JD; Gould MN
Cancer Chemother Pharmacol; 1994; 35(1):31-7. PubMed ID: 7987974
[TBL] [Abstract][Full Text] [Related]
15. Monoterpenes inhibit cell growth, cell cycle progression, and cyclin D1 gene expression in human breast cancer cell lines.
Bardon S; Picard K; Martel P
Nutr Cancer; 1998; 32(1):1-7. PubMed ID: 9824849
[TBL] [Abstract][Full Text] [Related]
16. Isoprenylation of proteins in the protozoan Giardia lamblia.
Luján HD; Mowatt MR; Chen GZ; Nash TE
Mol Biochem Parasitol; 1995 Jun; 72(1-2):121-7. PubMed ID: 8538683
[TBL] [Abstract][Full Text] [Related]
17. Modulation of the mevalonate pathway and cell growth by pravastatin and d-limonene in a human hepatoma cell line (Hep G2).
Kawata S; Nagase T; Yamasaki E; Ishiguro H; Matsuzawa Y
Br J Cancer; 1994 Jun; 69(6):1015-20. PubMed ID: 8198962
[TBL] [Abstract][Full Text] [Related]
18. Phase I and pharmacokinetic study of D-limonene in patients with advanced cancer. Cancer Research Campaign Phase I/II Clinical Trials Committee.
Vigushin DM; Poon GK; Boddy A; English J; Halbert GW; Pagonis C; Jarman M; Coombes RC
Cancer Chemother Pharmacol; 1998; 42(2):111-7. PubMed ID: 9654110
[TBL] [Abstract][Full Text] [Related]
19. Effect of S(-) perillic acid on protein prenylation and arterial smooth muscle cell proliferation.
Ferri N; Arnaboldi L; Orlandi A; Yokoyama K; Gree R; Granata A; Hachem A; Paoletti R; Gelb MH; Corsini A
Biochem Pharmacol; 2001 Dec; 62(12):1637-45. PubMed ID: 11755117
[TBL] [Abstract][Full Text] [Related]
20. R-Limonene metabolism in humans and metabolite kinetics after oral administration.
Schmidt L; Göen T
Arch Toxicol; 2017 Mar; 91(3):1175-1185. PubMed ID: 27325307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
